Updated 5.19.2023
CBD, short for cannabidiol, has gained significant attention for its potential therapeutic properties and a wide range of reported benefits. A non-intoxicating compound derived from hemp and cannabis, CBD could relieve symptoms of anxiety, pain, inflammation, and insomnia, among others.
CBD’s popularity skyrocketed after the 2018 Farm Bill legalized hemp, leading to a CBD boom in the beauty and wellness industry. However, the CBD market is now amidst a crowded landscape, with the emergence of other hemp-based cannabinoids like delta-8 THC. This influx of alternative cannabinoids presents consumers with various choices, prompting a reevaluation of CBD’s role in the ever-evolving cannabis industry.
CBD is a cannabinoid found in hemp and cannabis plants. In cannabis, CBD is second only to THC in prominence. But in hemp, CBD is the most potent compound.
CBD is legal (when derived from hemp) and will not get you high regardless of origin. In terms of its structure and mechanism of action, CBD is a trickly little compound that we still don’t fully understand. It doesn’t bind directly with the receptors in your endocannabinoid system as other cannabinoids do (we’ll get into that later).
CBD also has a limit on the dose-to-effectiveness ratio. The necessary personalization of taking CBD is part of the confusion surrounding its benefits. CBD has a U-shaped dose curve response, meaning higher doses don’t always work better or more effectively. There is a “sweet spot” of dosing to provide optimal effects, and that’s different for every person.
CBD comes from its acid precursor, CBDa, which transforms into CBD when heated through a process called decarboxylation.
But let’s back it up even further.
Hemp plants initially produce the “mother cannabinoid,” CBGa, in large quantities. As the plant matures, CBGa breaks down through a reaction called cannabidiolic acid synthase and becomes CBDa. CBDa later degrades into CBD when heated.
No, CBD is not intoxicating and will not get you high like THC will. But CBD is psychoactive, meaning it affects your brain, and you may notice some mental or physical effects, depending on the dose.
CBD is a heavily studied cannabinoid because it provides many of the same benefits as THC but without the intoxicating properties. This makes it a favorite for medical patients and researchers looking for non-psychoactive treatment options to common ailments.
CBD has anti-inflammatory properties that interact with neurotransmitters to change and reduce our perception of pain.
CBD has well-documented anxiolytic properties and can be beneficial for people with social anxiety disorders. But the dose size matters in correlation with its effectiveness.
A 2019 study tested CBD’s effects on public speaking anxiety. Participants received a placebo or a dose of CBD at 150 mg, 300 mg, or 600 mg. Scientists found that participants who received 300 mg had “significantly reduced anxiety” while public speaking, but there was no significant difference between the participants who received 150 mg v. 600 mg.
CBD has antidepressant effects in mice, and promising potential in humans, though studies are limited. A 2010 study suggested CBD counters depression by activating the serotonin receptor, 5-HT(1A). A 2019 study supports this, reporting CBD “promotes both a rapid and a sustained antidepressant effect in animal models” by inducing cellular and molecular changes in the hippocampus and prefrontal cortex in the brain, areas that are chemically affected by depression.
The science of CBD for sleep reveals mixed results.
So will CBD help you sleep better?
We can’t say for sure, but a self-reported 2021 study found that 42% of respondents used CBD to help them sleep better.
Additionally, a recent clinical trial evaluating the effectiveness of Charlotte's Web hemp extract revealed significant improvements in sleep quality among participants. The study showed that 60% of participants struggling with sleep issues experienced clinically meaningful improvements in sleep quality after taking Charlotte's Web Original Formula, compared to only 15% in the control group who did not take any hemp extract. This demonstrates the potential benefits of Charlotte's Web in addressing sleep-related challenges.
CBD is federally approved to treat seizures resulting from rare forms of epilepsy for patients as young as two years old and has been since 2018. A 2016 review examined five pediatric epilepsy clinics with 74 patients who took oil with a 20:1 CBD to THC ratio. They found 89% of the children reported a reduction in seizure frequency, with 18% reporting a 75-100% decrease.
The authors of the study note five children had adverse reactions, including drowsiness, irritability, and gastrointestinal distress, and ceased treatment.
CBD has neuroprotective properties that prevent hippocampal and cortical neurons from deteriorating.
CBD gets absorbed through the bloodstream, where it interacts (indirectly) with your endocannabinoid system. How effectively it gets into your bloodstream depends on the administration method.
If you smoke CBD, it is absorbed into the lungs first and then into the bloodstream. If you consume an edible, your body breaks the CBD down in your liver and digestive tract before entering your bloodstream. If you’re using a topical application of CBD, it’s absorbed into the skin and interacts with the endocannabinoid receptors that reside there.
The endocannabinoid system (ECS) is a complex chemical signaling system in the body. If you didn’t know you had an endocannabinoid system, you’re not alone- but every person (and, in fact, every mammal) has an ECS.
The purpose of your ECS is to process plant-based cannabinoids like CBD and endogenous cannabinoids like anandamide. The ECS has receptors on every organ in your body that help you stay healthy by improving biological functions.
Research on the ECS is still in fairly early stages, but experts have identified two primary receptors–CB1 and CB2. CB1 receptors are concentrated in the brain and nervous system and appear in your spinal cord and liver. CB2 receptors are present in the immune and gastrointestinal systems as well as the brain.
Remember when we said CBD was a trickly cannabinoid? Scientists know CBD activates your endocannabinoid system- but they don’t fully understand how. CBD doesn’t bind with CB1 or CB2 receptors like other cannabinoids. THC unquestionably binds to CB1, and for a while, researchers thought that CBD was a CB1 antagonist.
But CBD has shown little binding affinity for either receptor, leaving scientists to ponder its exact mechanism of action.
Here’s what we do know. CBD is polypharmacological, meaning it acts on multiple targets in the body. It seems to work mostly indirectly by modifying the effects of other compounds or changing certain processes. CBD doesn’t bind with your CB1 receptor, but it acts as a negative allosteric modulator, changing how CB1 interacts with THC.
As a result, CBD can actually negate or counteract some of the adverse side effects of THC, including anxiety, paranoia, and increased heart rate. CBD may increase the effect of endocannabinoids, like anandamide, in the body as well. Scientists believe CBD stops anandamide from being broken down too quickly, allowing this “bliss molecule” to build up in your system and amplify its effects.
CBD became a protected cannabinoid when hemp cultivation was federally legalized in 2018. But since this bill also protects hemp derivatives, innovative brands recently began experimenting with creating new compounds from CBD extracts.
Delta-8 reacts in the body like THC and doesn’t have much in common with CBD. But Delta-8 products as you know them wouldn’t exist without CBD. Delta-8 naturally occurs in quantities too small to commercially produce. In order to synthesize enough to sell, scientists typically transform CBD into Delta-8 THC through a chemical reaction spurred by a catalyst that converts crude oil into this THC isomer. Learn more about Delta-8 THC.
Like Delta-8, Delta-10 THC is another hemp-derived innovation that brands are creating through CBD conversion methods. The process is also similar, requiring a catalyst and chemical reaction. Delta-10 is newer to the mainstream market than Delta-8 and is less studied. Learn more about Delta-10 THC.
THCO-a or THCo Acetate does not naturally occur in hemp or cannabis plants, nor is it a THC isomer. It is, however, a derivative of hemp products. THCO-a is synthesized from Delta-8, which is typically first created by synthesizing CBD. Learn more about THCO-a.
CBD is increasingly common across the country, both in dispensaries and in CBD-specific stores. You can find CBD in flower form, but it can also be in oils, tinctures, edibles, topical treatments, and cartridges. As the legal market continues to grow, CBD beverages and skincare lines are also hitting the market.
CBD product availability varies by state, and not all forms may be available where you live. Some CBD products may contain THC if you’re purchasing in a recreationally legal state. However, in states without recreational cannabis, the CBD won’t have more than 0.3% THC as per federal law.
Though CBD is also available at gas stations and grocery stores across the county, those are not advisable places to purchase and consume CBD. Always buy CBD products from a dispensary or trusted hemp company that provides a COA to validate its components and safety.
Yes. You can consume CBD in any way THC can be ingested, including smoking the flower and vaping the extract. You’ll also find CBD in a number of tinctures and concentrates as well as in edibles and beverages.
CBD is everywhere in modern cannabis strains! While most strains are more THC forward, the 2018 Farm Bill combined with expanding legalization means CBD-forward strains are growing in popularity. Strains high in CBD tend to provide a chill, calming high that lacks the forcefulness of THC.
Yes, but it’s complicated because CBD comes from hemp and cannabis plants.
CBD derived from hemp is federally legal, thanks to the 2018 Farm Bill, which protects hemp cultivations with less than 0.3% THC. You can purchase CBD in almost all of the 50 states, but the products and consumption methods vary.
CBD derived from cannabis plants is not federally legal, however, each state has its own cannabis legislation.
After the 2018 Farm Bill passed, hemp was touted as a “get rich quick” crop for distressed farmers. And for the first year, it was. But the market was quickly flooded with too much supply to meet the demand, and hemp prices plummeted in 2019. Part of the problem was the lack of infrastructure for hemp manufacturing. Proper processing can turn hemp into several materials, from clothing fabric to housing insulation, but the primary market in the US focused on smokable CBD flower and ingestible or topical CBD products. Additionally, the high demand for psychoactive hemp-derived cannabinoids like Delta-8 and THCP have increased competition for market share.
Many CBD brands that based their entire value proposition on single-compound formulations have come and gone due to these issues.
Fortunately, CBD products still have a growing market and are more than just a trend that some think will soon fade. In fact, the global CBD market is expected to grow by 16.8% between 2022 and 2030, reaching $22.05 billion. Industry experts predict capital and deal flow could further increase with the potential federal legalization of marijuana.
CBD products are still in demand, but the market is more demanding and looking for other ingredients like adaptogens or other cannabinoids to interest them.
Other indicators of CBD’s resiliency is consumer trust and product diversification.
Wellness retailer Standard Dose reported that customers trust CBD more than other product lines, resulting in a 15-18% customer retention rate.
Sexual wellness and women’s health are two categories where CBD products continue expanding.
CBD demand is steadily rising, and long-term growth is expected over the next decade. Still, today’s numbers paint a complicated picture of wins and losses.
On the upside, smokable CBD Flower and CBG Flower prices experienced increases in April. Additionally, some hemp businesses reported increasing activity overall compared to 2022. The CBD and fiber sector hope to make gains with the new Farm Bill looming.
Like all cannabinoids, CBD potency is measured with a potency test from a verified third-party laboratory.
At ACS, we use Ultra-High Performance Liquid Chromatography (HPLC-UV) to test for the presence and potency of 25 cannabinoids, including CBD and THC. The LCUV machinery is the preferred instrument for edibles and extracts because it can test samples at room temperature without needing heat, which can influence the results.
At ACS, we understand the importance of accurate THC potency tests for brands to market products successfully. We test hemp and cannabis products for CBD as part of our 25 Analyte Potency Test. We also test for Delta-8 THC, Delta-10 THC, HHCP, THCP, THCP, THCBWith its ability to reduce pain, treat epilepsy and addictions, and lower anxiety levels, CBD is the gateway into a new form of plant medicine.
Want to test with us? We deliver precise results fast. Contact us today to learn more or schedule a potency test.